Savara Pharma (SVRA) - Uzoq muddatli qarzning kapitalga koeffitsiyenti
Savara Inc. (SVRA) hayotni saqlab qoluvchi dori vositalarini ishlab chiqishga e'tibor qaratgani sababli, kam uchraydigan respirator patologiyalarni davolovchi shifokorlar orasida yuqori obro'ga ega. Zamonaviy steril zonalarga ega ishlab chiqarish ob'ekti dori vositalari chiqishini ta'minlash uchun uzluksiz ishlamoqda. separate_debt_long_eq ko'rsatkichi 0.20 darajasida turibdi. Aksiyaning narxlar tarixi kompaniyaning APAP bilan kasallangan bemorlar uchun noyob inhalatsiya terapiyasi usulini ishlab chiqayotgani sababli uning salohiyatini namoyish etadi.
%20Uzoq%20muddatli%20qarzning%20kapitalga%20nisbati&width=1200&height=400&colorIndex=0&v=mvvwvvs9.gq-7b28iyo&start=20220704&end=20261031&filename=GURU_Markets_-_SVRA_-_Savara-Inc._-_Long-Term-Debt-to-Capital "SVRA: Savara Uzoq muddatli qarzning kapitalga nisbati 04.07.2022 - 31.10.2026 | 👁️GURU.Markets👁️")
Savara Inc. (SVRA) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- aksiya narxi va konsensus maqsadli narx:
- bozor kapitallashuvi ko'rsatkichlari:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Savara Inc.|SVRA - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati savarapharma.com|SVRA - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati Savara Inc.|SVRA - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz hajmi Savara|Tezkor likvidlik ko‘rsatkichi savarapharma.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
Kompaniyaning umumiy tahlili:Savara Inc - SVRA
Ushbu ko'rsatkich kapital tuzilmasidagi uzoq muddatli majburiyatlar ulushini o'lchab, moliyaviy leveraj darajasini va kompaniyaning foiz stavkalari tebranishlariga chidamliligini aniqlaydi. Uzoq muddatli qarzlarning kapitalga nisbatini tahlil qilish Savara Inc. (SVRA) eksklyuziv orfan dori vositalarini ishlab chiqishni qanchalik samarali moliyalashtirayotganini, shuningdek, uzoq muddatli kreditlarni kafolatlangan bozor talabiga ega yuqori marjali aktivlarga qanchalik muvaffaqiyatli aylantirayotganini baholash imkonini beradi.
Muhim raqobatchilar
argenx N.V. - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati BNTX|ABVX (Abivax S.A.) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati ADMA (ADMA Biologics)|Uzoq muddatli qarzning kapitalga nisbati protagonist-inc.com PTGX|IMVT - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti KNSA (Kiniksa Pharmaceuticals, Ltd.)|Grifols Group (GRFS) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Adaptive Biotechnologies Inc.|CLDX (Celldex Therapeutics) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati auriniapharma.com|Uzoq muddatli qarzning o'z kapitaliga nisbati BCRX (BioCryst Pharmaceuticals)|VERA (Vera Therapeutics Inc) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati DNTH (Dianthus Pharma)|Uzoq muddatli qarzdorlikning kapitalga nisbati Pharvaris Pharma (PHVS)|ABCL - Uzoq muddatli qarzning o'z kapitaliga nisbati|tourmalinebio.com (TRML) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Precigen (PGEN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Pharming Group NV|Uzoq muddatli qarzning o'z kapitaliga nisbati NKTR|Uzoq muddatli qarzning kapitalga nisbati Upstream Pharma|Uzoq muddatli qarzning o'z kapitaliga nisbati Zenas Biopharma Inc (ZBIO)|immunome.com - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati GOSS (Gossamer Bio)|KalVista Pharma (KALV) - Uzoq muddatli majburiyatlarning kapitalga nisbati|SEPN - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati Pieris Corp PVLA|RIGL: Uzoq muddatli qarzning kapitalga nisbati|anaptysbio.com (ANAB) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati ATXS|Uzoq muddatli qarzning o'z kapitaliga nisbati ENGN|Uzoq muddatli qarzning kapitalga nisbati RAPT|Uzoq muddatli qarzning kapitalga nisbati aerovatetx.com (JBIO)|Uzoq muddatli qarzning o'z kapitaliga nisbati Aclaris Therapeutics ACRS|Uzoq muddatli qarzning kapitalga koeffitsiyenti KYTX|Tiziana Life Sciences Ltd - Uzoq muddatli qarzning kapitalga nisbati|CABA - Uzoq muddatli qarzning kapitalga nisbati|VTYX (Ventyx Bio) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Theratechnologies, Inc - Uzoq muddatli qarzning kapitalga koeffitsiyenti|AVTX (Avalo Therapeutics, Inc) - Uzoq muddatli qarzning kapitalga nisbati|eledon.com (ELDN) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Agenus Inc. (AGEN)|Climb Bio Inc. - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati ZURA (Zura Bio Limited)|ATYR - Uzoq muddatli qarzning o'z kapitaliga nisbati|ADAG: Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati ImageneBio Inc IMA|shattucklabs.com (STTK) - Uzoq muddatli qarzning o'z kapitaliga nisbati|EQ - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati CNTB|Uzoq muddatli qarzning o'z kapitaliga nisbati IMUX|Uzoq muddatli qarzning o'z kapitaliga nisbati Atara Biotherapeutics (ATRA)|IFRX (inflarx.de) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati XFOR (X4 Pharmaceuticals, Inc.)|Uzoq muddatli qarzning kapitalga nisbati Adicet Bio Inc. ACET|CELU - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati INMB|BRNS: Uzoq muddatli qarzning kapitalga nisbati|kezarlifesciences.com - Uzoq muddatli qarzning kapitalga koeffitsiyenti|SABS (SAB Biotherapeutics, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati Akari Therapeutics PLC|Uzoq muddatli qarzning o'z kapitaliga nisbati Enlivex Therapeutics (ENLV)|QTTB (q32bio.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati GeoVax Labs, Inc. GOVX|EDSA - Uzoq muddatli qarzning o'z kapitaliga nisbati|iBio - Uzoq muddatli qarzning kapitalga nisbati|CARM - Uzoq muddatli qarzning kapitalga nisbati|XTLB (XTL Biopharmaceuticals, Ltd.) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Bolt Biotherapeutics, Inc. - Uzoq muddatli qarzning kapitalga koeffitsiyenti|HCWB (HCW Biologics, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Aptevo (APVO) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati AIM ImmunoTech (AIM)|Uzoq muddatli qarzning o'z kapitaliga nisbati aditxt.com ADTX|Uzoq muddatli qarzning o'z kapitaliga nisbati GRI Bio Corp GRI|XRTX - Uzoq muddatli qarzning o'z kapitaliga nisbati|HIND: Uzoq muddatli qarzning o'z kapitaliga nisbati|REVB - Uzoq muddatli qarzning kapitalga nisbati|Indaptus Therapeutics, Inc. (INDP) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi SCNI|CALI (CalciMedica Inc) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Affimed Therapeutics AFMD|Uzoq muddatli qarzning o'z kapitaliga nisbati Allakos Inc. (ALLK)|Uzoq muddatli qarzdorlikning kapitalga nisbati hookipapharma.com|Uzoq muddatli qarzning kapitalga nisbati IGMS (IGM Biosciences)|Uzoq muddatli qarzning kapitalga nisbati iTeos Therapeutics Inc ITOS|OCEA: Uzoq muddatli qarzning o'z kapitaliga nisbati|TCBP: Uzoq muddatli qarzning o'z kapitaliga nisbati|THRD: Uzoq muddatli qarzning kapitalga nisbati